Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
0.7000
-0.1584 (-18.45%)
At close: Mar 28, 2025, 4:00 PM
0.8288
+0.1288 (18.40%)
After-hours: Mar 28, 2025, 7:58 PM EDT
Accelerate Diagnostics Revenue
In the year 2024, Accelerate Diagnostics had annual revenue of $11.70M, down -2.99%. Accelerate Diagnostics had revenue of $2.82M in the quarter ending December 31, 2024, a decrease of -6.97%.
Revenue (ttm)
$11.70M
Revenue Growth
-2.99%
P/S Ratio
1.39
Revenue / Employee
$87,299
Employees
134
Market Cap
17.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.70M | -361.00K | -2.99% |
Dec 31, 2023 | 12.06M | -693.00K | -5.43% |
Dec 31, 2022 | 12.75M | 970.00K | 8.23% |
Dec 31, 2021 | 11.78M | 617.00K | 5.53% |
Dec 31, 2020 | 11.17M | 1.87M | 20.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
AXDX News
- 9 days ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 9 days ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 2 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 6 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 8 months ago - Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha